Programs currently tracked for this institution in the public Translational Deal Radar dataset.
Dual-target CAR-NK cells is flagged as a low confidence because it has an active early-phase oncology cell-therapy trial at Beijing Biotech, with a unlinked patent signal linked through public patent-search heuristics. Manual review is still required.
Phase1 · Recruiting
View assetEB-DTKN-401 allogeneic dual-target CSPG4/GD2 CAR-NK cells is flagged as a low confidence because it has an active early-phase oncology cell-therapy trial at Beijing Biotech, with a unlinked patent signal linked through public patent-search heuristics. Manual review is still required.
Phase1 · Recruiting
View assetEB-DT-NK-UC101 is flagged as a low confidence because it has an active early-phase oncology cell-therapy trial at Beijing Biotech, with a unlinked patent signal linked through public patent-search heuristics. Manual review is still required.
Phase1 · Recruiting
View assetEB-DT-CAR-NK is flagged as a low confidence because it has an active early-phase oncology cell-therapy trial at Beijing Biotech, with a unlinked patent signal linked through public patent-search heuristics. Manual review is still required.
Phase1 · Recruiting
View assetEB-DUALNK is flagged as a low confidence because it has an active early-phase oncology cell-therapy trial at Beijing Biotech, with a unlinked patent signal linked through public patent-search heuristics. Manual review is still required.
Phase1 · Recruiting
View assetEB-DUO-CAR-NK-CEA/GCC is flagged as a low confidence because it has an active early-phase oncology cell-therapy trial at Beijing Biotech, with a unlinked patent signal linked through public patent-search heuristics. Manual review is still required.
Phase1 · Recruiting
View asset